Optum’s 2024 clinic closures: What ASCs need to know

Optum, the country’s largest employer of physicians and parent company of ASC chain SCA Health, has revealed plans to shutter several clinics so far in 2024. 

Advertisement

The company has also conducted layoffs around the country, including locations in Washington, Texas and West Virginia, and announced that it is shuttering its telehealth business.

Here’s a state-by-state breakdown of the locations Optum has annouced plans to shutter so far in 2024:

California:

In July, Optum announced plans to terminate 524 employees from Sept. 16 through January 2025 at clinic and administrative office locations in Hayward, Glendora, Montbello, Covina, Pasadena, Long Beach, Los Angeles, Irvine, Beaumont, Redlands, Highland, El Segundo, and Cerritos. 

Optum also announced permanent closures at an additional 15 locations, including urgent and primary care clinics, infusion services facilities and medical groups.

Colorado:

Optum is closing three urgent care clinics in Colorado Springs and Monument by Aug. 1.

Florida:

Optum is closing a WellMed clinic in Tampa by Aug. 19.

Ohio:

In May, Optum said it would close a Change Healthcare facility in Toledo, laying off 129. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.